Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer

Press/Media

Period13 Oct 2020

Media coverage

1

Media coverage

  • TitleTargovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date13/10/20
    PersonsDmitriy Zamarin
View all 1
View less